Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:ageRange |
18 years and older
|
| gptkbp:allocates |
Randomized
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:completedIn |
December 2020
|
| gptkbp:conditionStudied |
gptkb:COVID-19
|
| gptkbp:enrollment |
440
|
| https://www.w3.org/2000/01/rdf-schema#label |
NCT04368728
|
| gptkbp:intervention |
gptkb:Azithromycin
Hydroxychloroquine |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:mask |
Double-blind
|
| gptkbp:officialName |
Hydroxychloroquine and Azithromycin for the Treatment of COVID-19 in Outpatients: A Randomized, Double-Blind, Placebo-Controlled Trial
|
| gptkbp:purpose |
Treatment
|
| gptkbp:recognizedBy |
gptkb:NCT04368728
|
| gptkbp:result |
Hospitalization or death
|
| gptkbp:sponsor |
gptkb:University_of_Washington
|
| gptkbp:startDate |
April 2020
|
| gptkbp:status |
Completed
|
| gptkbp:studyType |
Interventional
|
| gptkbp:bfsParent |
gptkb:Pfizer_COVID-19_vaccine_trial
|
| gptkbp:bfsLayer |
7
|